12 November 2024 Ashoka WhiteOak Emerging Markets Trust plc Issue of Equity Ashoka WhiteOak Emerging Markets Trust plc (the ‘Company’) announces that it has issued 550,000 new ordinary shares of one penny each (the ‘Ordinary Shares’) pursuant to its block listing facility. The Ordinary Shares will be …
FIDELITY CHINA SPECIAL SITUATIONS PLC (the 'Company') TRANSACTION IN OWN SHARES The Board of the Company announces that it has repurchased for cancellation. Number of shares repurchased: 250,000 Date of transaction: 12 November 2024 Average share price paid per share (GBp): 214.000 Lowest share price paid per share (GBp): …
Fondia Plc Company release 12.11.2024 at 6.45 p.m. EET Fondia – Acquisition of own shares 12.11.2024 Fondia Plc First North Finland Date 12.11.2024 Exchange transactions Buy Share class FONDIA Amount, shares 240 Average price/share, EUR 5,897708 Total price, EUR 1415,45 The shares …
The unit issue in Hubbster Group AB (“The Company”) is now registered with the Swedish Companies Registration Office and the last day of trading in paid subscribed units has been set for November 13, 2024. The first day of trading for the Company’s warrants series 2 (TO 2) and …
Press Release no. 05-2024November 12, 2024 Copenhagen, Denmark – November 12, 2024 – Audientes A/S (“Audientes”), an innovative Danish hearing health company focused on affordable, self-fitting hearing aids and hearables, is pleased to announce the appointment of Stefan Lundström as European Sales and Marketing Director. With his impressive background …
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Henry Spain Investment Services (b) Owner or controller of interests and short positions disclosed, if …
Last week, Saniona announced that its partner Medix in Mexico had not received regulatory approval for tesofensine. In a new update, Saniona clarifies that Medix, as the primary applicant and manager of the approval process in Mexico, is actively engaging with the regulatory agency to resolve the matter. Read the …
Orthex Corporation, Stock exchange release, 12 November 2024 at 4.00 p.m. EET Orthex Corporation and Alex Nielsen, Sales Director, Europe and International Markets and member of the company’s Management Team, have agreed that Mr. Nielsen will leave the company as of 30 November 2024. Nielsen has been a member of …
Hamilton, Bermuda, November 12, 2024 – Reference is made to the stock exchange announcement by Euronext Oslo Børs on 5 November 2024, which announced the receipt of an application for admission to trading on Euronext Oslo Børs from Paratus Energy Services Ltd. (the "Company") as a transfer from Euronext Growth …
Hørsholm, Denmark, 12 November 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion"), a clinical-stage biotechnology company with a focused pipeline of vaccine candidates targeting infectious diseases and cancer, today announced that positive new preclinical data from its ongoing cytomegalovirus (CMV) vaccine program collaboration with Evaxion Biotech A/S …
